Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 27:8:76.
doi: 10.3389/fphar.2017.00076. eCollection 2017.

Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review

Uday P Kundap  1 , Saatheeyavaane Bhuvanendran  1 , Yatinesh Kumari  1 , Iekhsan Othman  1 , Mohd Farooq Shaikh  1
Affiliations
Review

Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review

Uday P Kundap et al. Front Pharmacol. .

Abstract

A Central nervous system (CNS) disease is the one which affects either the spinal cord or brain and causing neurological or psychiatric complications. During the nineteenth century, modern medicines have occupied the therapy for many ailments and are widely used these days. Herbal medicines have often maintained popularity for historical and cultural reasons and also considered safer as they originate from natural sources. Embelin is a plant-based benzoquinone which is the major active constituent of the fruits of Embelia ribes Burm. It is an Indo-Malaysian species, extensively used in various traditional medicine systems for treating various diseases. Several natural products including quinone derivatives, which are considered to possess better safety and efficacy profile, are known for their CNS related activity. The bright orange hydroxybenzoquinone embelin-rich fruits of E. ribes have become popular in ethnomedicine. The present systematic review summarizes the effects of embelin on central nervous system and related diseases. A PRISMA model for systematic review was utilized for search. Various electronic databases such as Pubmed, Springer, Scopus, ScienceDirect, and Google Scholar were searched between January 2000 and February 2016. Based on the search criteria for the literature, 13 qualified articles were selected and discussed in this review. The results of the report showed that there is a lack of translational research and not a single study was found in human. This report gives embelin a further way to be explored in clinical trials for its safety and efficacy.

Keywords: CNS disorders; embelin; natural product; neurodegenerative diseases; neuropharmacology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Image of the plant Embelia ribes and chemical structure of embelin.
Figure 2
Figure 2
Mechanism of action of embelin on various CNS disorders.
Figure 3
Figure 3
Flow chart of study selection procedure.
Figure 4
Figure 4
Animal models of ischemic stroke model.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Afzal M., Gupta G., Kazmi I., Rahman M., Upadhyay G., Ahmad K., et al. (2012). Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomed. Aging Pathol. 2, 45–47. 10.1016/j.biomag.2012.03.003 - DOI
    1. Ahn K. S., Sethi G., Aggarwal B. B. (2007). Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol. 71, 209–219. 10.1124/mol.106.028787 - DOI - PubMed
    1. Allensworth J. L., Aird K. M., Aldrich A. J., Batinic-Haberle I., Devi G. R. (2012). XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol. Cancer Ther. 11, 1518–1527. 10.1158/1535-7163.MCT-11-0787 - DOI - PubMed
    1. Banks W. A. (2009). Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9:S3. 10.1186/1471-2377-9-S1-S3 - DOI - PMC - PubMed
    1. Borlongan C. V., Koutouzis T. K., Sanberg P. R. (1997). 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21, 289–293. 10.1016/S0149-7634(96)00027-9 - DOI - PubMed